Literature DB >> 1114343

Malignant hemangioendotheliomas produced by subcutaneous inoculation of Balb/3T3 cells attached to glass beads.

C W Boone.   

Abstract

The Balb/3T3 mouse embryo cell line has been frequently used in cancer research as representative of nontumorigenic cells with the characteristic in vitro properties of postconfluence inhibition of cell division, low saturation density, and anchorage dependence. On the reasoning that anchorage dependence might also apply in vivo, each of nine mice were subcutaneously inoculated with an average of 15,400 Balb/3T3 cells attached to two glass beads 3 millimeters in diameter. After 8 weeks, all the mice had developed large bloody tumors that microscopically proved to be hemangioendotheliomas. Ther inoculation of Balb/3T3 cells alone or beads alone produced no tumors. Transplants of each tumor into normal mice grew to kill the animal within 6 weeks. Tumor cells from collagenase-disaggregated tumor tissue had a plating efficiency of 21.2 percent compared to that of normal adult subcutaneous fibroblasts of less than 0.1 percent. The tumor cells in vitro closely resembled Balb/3T3 cells in appearance and were tumorigenic at a dose of 10-4 cells. A second, repeat experiment produced the same type of tumors grossly and microscopically in 17 of 25 mice between 99 and 211 days after inoculation of the Balb/3T3 cells attached to glass beads. These findings require a reassessment of the postulate that low saturation density, postconfluence of cell division, and anchorage dependence are characteristic in vitro properties only of nonneoplastic cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1114343     DOI: 10.1126/science.1114343

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  31 in total

1.  Ascorbate induction of collagen synthesis as a means for elucidating a mechanism of quantitative control of tissue-specific function.

Authors:  R I Schwarz; R B Mandell; M J Bissell
Journal:  Mol Cell Biol       Date:  1981-09       Impact factor: 4.272

2.  Plasma membrane alteration associated with malignant transformation in culture.

Authors:  N B Gilula; R R Eger; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

3.  In the interest of clearer communication.

Authors:  L Hayflick
Journal:  In Vitro Cell Dev Biol       Date:  1990-01

4.  Complexes of inorganic pyrophosphate, orthophosphate, and calcium as stimulants of 3T3 cell multiplication.

Authors:  H Rubin; H Sanui
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

5.  Rates of aggregation, loss of anchorage dependence, and tumorigenicity of cultured cells.

Authors:  T C Wright; T E Ukena; R Campbell; M J Karnovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

6.  Initiation points for DNA replication in nontransformed and simian virus 40-transformed BALB/c 3T3 cells.

Authors:  A Oppenheim; R G Martin
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

Review 7.  Viruses and human cancers: a long road of discovery of molecular paradigms.

Authors:  Martyn K White; Joseph S Pagano; Kamel Khalili
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

8.  Chronic inflammation predisposing to cancer metastasis: lesson learned from a chronically embedded foreign body in a duodenal diverticulum.

Authors:  Amir Kalani; Malathy Kapali; Tashia Orr; Alison Petrie; Michael Lawson
Journal:  J Gastrointest Cancer       Date:  2014-12

9.  Cell cycle dependent genes inducible by different mitogens in cells from different species.

Authors:  C W Gibson; S R Rittling; R R Hirschhorn; L Kaczmarek; B Calabretta; C D Stiles; R Baserga
Journal:  Mol Cell Biochem       Date:  1986-06       Impact factor: 3.396

Review 10.  Cancer genes: rare recombinants instead of activated oncogenes (a review).

Authors:  P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.